Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma × Practice Guidelines as Topic × Clear all

Phase

Phase NA 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Hematologic Neoplasms 2 Teratoma 1 Stroke 1 Pulmonary Disease, Chronic Obstructive 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Kidney Failure, Chronic 1 Hepatitis B 1 Hematopoietic and Lymphatic System Neoplasm 1 Endometrial Clear Cell Adenocarcinoma 1 Endodermal Sinus Tumor 1 Diabetes Mellitus 1 Coronary Artery Disease 1 Colonic Neoplasms 1 Carcinoma, Embryonal 1 COVID-19 1 Breast Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 48 Vincristine 46 Doxorubicin 45 Prednisone 37 Rituximab 36 Radiotherapy 30 Etoposide 27 Cytarabine 18 Filgrastim 17 Bleomycin 17 Methotrexate 15 Dexamethasone 12 VAP-cyclo protocol 11 Vinblastine 10 Prednisolone 10 Carmustine 10 Peripheral Blood Stem Cell Transplantation 9 Mitoxantrone 8 Mercaptopurine 8 Melphalan 8 Dacarbazine 8 Leucovorin 7 Lenalidomide 7 ibrutinib 6 Procarbazine 6 Ifosfamide 6 Granulocyte Colony-Stimulating Factor 6 Gemcitabine 6 Hydrocortisone 5 Epoetin Alfa 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05006482 2026-01-13

GEM-S

University of Rochester

Phase 3 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡